Sicart Associates LLC Sells 1,437 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Sicart Associates LLC decreased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 3.0% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 46,041 shares of the financial services provider’s stock after selling 1,437 shares during the period. iShares Biotechnology ETF accounts for 2.2% of Sicart Associates LLC’s portfolio, making the stock its 20th largest position. Sicart Associates LLC’s holdings in iShares Biotechnology ETF were worth $6,087,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the company. Darwin Wealth Management LLC purchased a new stake in iShares Biotechnology ETF during the third quarter worth $29,000. Highline Wealth Partners LLC purchased a new stake in iShares Biotechnology ETF during the third quarter worth $30,000. Ashton Thomas Securities LLC purchased a new stake in iShares Biotechnology ETF during the third quarter worth $36,000. Modus Advisors LLC purchased a new stake in iShares Biotechnology ETF during the fourth quarter worth $41,000. Finally, Voisard Asset Management Group Inc. purchased a new stake in iShares Biotechnology ETF during the third quarter worth $59,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

iShares Biotechnology ETF stock opened at $132.96 on Friday. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The business has a fifty day moving average of $136.94 and a two-hundred day moving average of $141.80.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.